SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1002]
GTX635791
ApplicationsELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Spike RBD antibody [HL1002]
- Delivery Days Customer9
- Application Supplier Note*Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL1002
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Liu TW, Hsu SJ, Hsieh YSY, et al. Polymethoxyflavone from Citrus depressa as an inhibitor against various variants of SARS-CoV-2 spike protein. J Ethnopharmacol. 2024,320:117412. doi: 10.1016/j.jep.2023.117412Read this paper
- Lee CY, Nguyen AT, Doan LH, et al. Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects. Viruses. 2023,15(3). doi: 10.3390/v15030641Read this paper
- Doan LH, Chu LW, Huang ZY, et al. Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2. Front Pharmacol. 2022,13:905197. doi: 10.3389/fphar.2022.905197Read this paper
- Yeh YC, Doan LH, Huang ZY, et al. Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro. Front Pharmacol. 2021,12:765553. doi: 10.3389/fphar.2021.765553Read this paper